News from leo pharma a/s A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jul 27, 2017, 09:01 ET LEO Pharma Ranks Second in Global Clinical Trials Transparency Audit

New top 50 list ranks LEO Pharma in second position, leading the global pharma industry in commitments to increase access to clinical trials...


Jul 20, 2017, 03:00 ET LEO Pharma Receives Marketing Authorisation for Kyntheum® (Brodalumab), a New Biologic for the Treatment of Moderate-to-Severe Plaque Psoriasis in the European Union

LEO Pharma today announced that the European Commission has granted marketing authorisation for Kyntheum® (brodalumab), a new biologic for the...


Jun 23, 2017, 02:00 ET LEO Pharma Appoints Chris Posner to Lead US Business

LEO Pharma today announced that it appointed Chris Posner Executive Vice President Region US and President & CEO, LEO Pharma, Inc. From July 15,...


Jun 15, 2017, 01:00 ET LEO Pharma Starts Phase 3 Clinical Study for Tralokinumab in Atopic Dermatitis

LEO Pharma today announced that the first patients have been dosed in a phase 3 clinical study of tralokinumab. Tralokinumab is an investigational...


Mar 03, 2017, 09:00 ET LEO Pharma Announces Positive Results From Phase 2b Clinical Study for Tralokinumab in Atopic Dermatitis

LEO Pharma today announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients with moderate to ...


Jul 01, 2016, 02:16 ET LEO Pharma Enters Biologics Through Strategic Partnership With AstraZeneca

LEO Pharma is a significant step closer to realising its vision of becoming the preferred dermatology care partner following a strategic partnership...


Mar 21, 2016, 04:00 ET LEO Pharma Receives Scientific Approval of Enstilar® for the Treatment of Psoriasis in EU

The marketing approval of Enstilar® would make it the first fixed combination topical foam treatment for people living with psoriasis vulgaris in the ...


Nov 11, 2015, 05:59 ET LEO Pharma to Acquire Global Dermatology Portfolio from Astellas

LEO Pharma A/S, a global healthcare company dedicated to helping people achieve healthy skin, and Japanese pharmaceutical company Astellas Pharma Inc....


Jun 10, 2015, 11:10 ET De nouvelles données indiquent qu'Enstilar®, le traitement expérimental du psoriasis de LEO Pharma A/S, permet le soulagement rapide des démangeaisons chez les patients avec psoriasis

LEO Pharma A/S annonce ce jour que selon de nouvelles données présentées au 23e Congrès mondial de dermatologie, sa mousse en aérosol expérimentale à ...


Jun 10, 2015, 10:06 ET Neue Daten zeigen, dass Prüfpräparat zur Behandlung von Psoriasis von LEO Pharma A/S, Enstilar®, eine schnelle Juckreizminderung für an Psoriasis erkrankten Patienten bietet

LEO Pharma A/S gab heute bekannt, dass neue auf dem 23. Weltkongress für Dermatologie vorgestellte Daten belegen, dass der Sprühschaum des...


Jun 10, 2015, 02:00 ET New Data Shows LEO Pharma A/S Investigational Psoriasis Treatment, Enstilar®, Provides Rapid Itch Relief for Psoriasis Patients

LEO Pharma A/S today announced that new data being presented at the 23rd World Congress of Dermatology shows aerosol foam Enstilar®...


Jun 10, 2015, 02:00 ET El tratamiento Enstilar® de LEO Pharma A/S ofrece un rápido alivio del picor de la psoriasis

- Los nuevos datos muestran que el tratamiento investigacional de la psoriasis de LEO Pharma A/S, Enstilar®, ofrece un rápido alivio del picor para...


Mar 19, 2013, 08:00 ET Bei LEO Pharma stehen Patienten im Mittelpunkt der Innovation

LEO Pharma kündigt eine gemeinsame Entwicklungsvereinbarung mit der National Psoriasis Foundation (NPF) in den Vereinigten Staaten an, bei der...


Mar 19, 2013, 08:00 ET LEO Pharma sætter patienter i centrum for innovation

LEO Pharma offentliggør en aftale om co-creation med National Psoriasis Foundation (NPF) i USA. Aftalen sætter patienter i centrum for LEO Pharmas...


Mar 19, 2013, 08:00 ET LEO Pharma coloca pacientes no coração da inovação

A LEO Pharma anuncia um acordo de cocriação com a Fundação Nacional de Psoríase (NPF), nos Estados Unidos, que coloca os pacientes no coração do...


Mar 19, 2013, 08:00 ET LEO Pharma Pone a Pacientes en el Centro de la Innovación

LEO Pharma anuncia un acuerdo de cocreación con la National Psoriasis Foundation (NPF) en Estados Unidos que sitúa a los pacientes en el centro del...


Mar 19, 2013, 08:00 ET LEO Pharma pone a los pacientes en el centro de la innovación

LEO Pharma anuncia un acuerdo de co-creación con la Fundación Nacional de la Psoriasis (FNP) en Estados Unidos que pone a los pacientes en el centro...


Mar 19, 2013, 08:00 ET LEO Pharma place les patients au cœur de l'innovation

LEO Pharma annonce un accord de co-création avec la National Psoriasis Foundation (NPF) aux États-Unis qui place les patients au cœur du processus...


Mar 19, 2013, 08:00 ET LEO Pharma Puts Patients at the Heart of Innovation

LEO Pharma announces a co-creation agreement with the National Psoriasis Foundation (NPF) in the United States that puts patients at the heart of LEO ...


Mar 19, 2013, 08:00 ET LEO Pharma Puts Patients at the Heart of Innovation

LEO Pharma announces a co-creation agreement with the National Psoriasis Foundation (NPF) in the United States that puts patients at the heart of LEO ...


Oct 03, 2012, 09:00 ET LEO Pharma Revela Nueva Estrategia de Colaboración Científica

LEO Pharma ha anunciado planes de establecer cinco colaboraciones de investigación estratégica a largo plazo en cuatro países para finales del...


Oct 03, 2012, 08:00 ET LEO Pharma Unveils new Scientific Collaboration Strategy

LEO Pharma has announced plans to establish five long-term, strategic research collaborations in four countries by the end of next year. The...


Oct 03, 2012, 07:00 ET LEO Pharma divulga nova estratégia de colaboração científica

A LEO Pharma anunciou planos para instituir cinco iniciativas de colaboração estratégica para pesquisas, de longo prazo, em quatro países, até o...


Oct 03, 2012, 02:00 ET LEO Pharma presenta una nueva estrategia de colaboración científica

LEO Pharma ha anunciado planes para establecer cinco colaboraciones de investigación estratégica a largo plazo en cuatro países para finales del...


Oct 03, 2012, 02:00 ET LEO Pharma stellt neue Strategie zur wissenschaftlichen Zusammenarbeit vor

LEO Pharma hat angekündigt, bis Ende nächsten Jahres fünf langfristige, strategische Kooperationen in vier Ländern zu etablieren. Die ehrgeizige...